First Command Advisory Services’s Bristol-Myers Squibb BMY Stock Holding History

First Command Advisory Services's BMY Position: Q2 2026 in Review

First Command Advisory Services reduced its Bristol-Myers Squibb (BMY) stake by 10% in Q2 2026, selling an estimated $18.4K and leaving 2,729 shares worth $157K. The position accounts for ﹤0.01% of the portfolio, ranked #227.

First Command Advisory Services first reported a position in BMY in Q3 2020 and has held it in 14 quarters since. The position peaked at $1.04M in Q3 2023. 2,513 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

• First Command Advisory Services held 2,729 shares of Bristol-Myers Squibb worth $157K as of Q2 2026.
• First Command Advisory Services sold 320 Bristol-Myers Squibb shares in Q2 2026, an estimated $18.4K.
• Bristol-Myers Squibb made up ﹤0.01% of First Command Advisory Services's portfolio in Q2 2026, its #227 holding.
• First Command Advisory Services first reported a position in Bristol-Myers Squibb in Q3 2020 and has held it in 14 quarters since.
• First Command Advisory Services's Bristol-Myers Squibb position peaked at $1.04M in Q3 2023.
• 2,513 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on First Command Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.